Physician profile
Forrest A Hanke
NPI 1295831279
$955.22
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $802 · 2020: $153.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $217.80 | 2019 | |
| Mannkind Corporation | $141.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $79.60 | 2019-2020 | |
| Astellas Pharma US INC | $50.02 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.98 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.96 | 2019 | |
| Allergan, INC. | $39.64 | 2019-2020 | |
| Novo Nordisk INC | $36.54 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $36.44 | 2019-2020 | |
| Eisai INC. | $34.88 | 2019 | |
| Novartis Pharmaceuticals Corporation | $32.16 | 2019 | |
| Amarin Pharma, INC. | $30.59 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $28.77 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $22.22 | 2019 | |
| Genentech USA, INC. | $15.60 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.54 | 2020 | |
| Pfizer INC. | $13.94 | 2019 | |
| Abbvie INC. | $12.58 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.19 | 2019 | |
| Glaxosmithkline, LLC. | $11.83 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.67 | 2020 | |
| Shire North American Group INC | $11.61 | 2019 | |
| Lilly USA, LLC | $11.47 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Forrest Hanke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.